reviewTop 1% cited
Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates
Advanced Drug Delivery Reviews · 2007 · Vol. 59(7) · pp. 617–630
N. Blagden✉(University of Bradford)Marcel de Matas(University of Bradford)Pauline T. Gavan(University of Bradford)P. York(University of Bradford)
Crystallization and Solubility StudiesDrug Solubulity and Delivery SystemsCrystallography and molecular interactionsDissolutionSolubilityCrystallizationBioavailabilityCrystal habitAmorphous solidActive ingredientCrystal (programming language)MetastabilityCrystal engineering
MeSH terms
Biological AvailabilityChemistry, PharmaceuticalCrystallizationPharmaceutical PreparationsSolubilitySolventsDrug Design
Citations
1,412
FWCI
18.31
field-weighted impact
References
119
Percentile
100%
vs. same field & year
Citations per year
Cited by
Effects of Crystal Form on Solubility and Pharmacokinetics: A Crystal Engineering Case Study of Lamotrigine
Crystal Growth & Design · 2009 · 247 citations
Applying Hot-Stage Microscopy to Co-Crystal Screening: A Study of Nicotinamide with Seven Active Pharmaceutical Ingredients
Crystal Growth & Design · 2008 · 343 citations
Solubility Advantage of Amorphous Drugs and Pharmaceutical Cocrystals
Crystal Growth & Design · 2011 · 977 citations
Hierarchy of Supramolecular Synthons: Persistent Carboxylic Acid···Pyridine Hydrogen Bonds in Cocrystals That also Contain a Hydroxyl Moiety
Crystal Growth & Design · 2008 · 469 citations
Pharmaceutical Cocrystals and Their Physicochemical Properties
Crystal Growth & Design · 2009 · 1,459 citations
Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: Basic approaches and practical applications
International Journal of Pharmaceutics · 2011 · 1,155 citations
Pharmaceutical cocrystals: An overview
International Journal of Pharmaceutics · 2011 · 642 citations
Supersaturating Drug Delivery Systems: The Answer to Solubility-Limited Oral Bioavailability?
Journal of Pharmaceutical Sciences · 2009 · 915 citations
References
Nanosuspensions as particulate drug formulations in therapy
Advanced Drug Delivery Reviews · 2001 · 1,355 citations
Spectroscopic Characterization of Interactions Between PVP and Indomethacin in Amorphous Molecular Dispersions
Pharmaceutical Research · 1997 · 887 citations
Use of a Glutaric Acid Cocrystal to Improve Oral Bioavailability of a Low Solubility API
Pharmaceutical Research · 2006 · 685 citations
Crystal Engineering of the Composition of Pharmaceutical Phases: Multiple-Component Crystalline Solids Involving Carbamazepine
Crystal Growth & Design · 2003 · 531 citations
Amorphous pharmaceutical solids: preparation, characterization and stabilization
Advanced Drug Delivery Reviews · 2001 · 1,366 citations
Phase Solubility Diagrams of Cocrystals Are Explained by Solubility Product and Solution Complexation
Crystal Growth & Design · 2005 · 308 citations
Encoding and decoding hydrogen-bond patterns of organic compounds
Accounts of Chemical Research · 1990 · 4,564 citations
Supramolecular Synthons in Crystal Engineering—A New Organic Synthesis
Angewandte Chemie International Edition in English · 1995 · 4,793 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.